Bank of New York Mellon
ACRV icon

Bank of New York Mellon’s Acrivon Therapeutics ACRV Stock Holding History

Bank of New York Mellon’s Portfolio ACRV Stock Details ACRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
2025
Q1 		$56.1K Hold
2024
Q4 		$166K Sell
2024
Q3 		$207K Sell
2024
Q2 		$212K Buy
2024
Q1 		$175K Sell
2023
Q4 		$122K Hold
2023
Q3 		$237K Hold
2023
Q2 		$321K Buy
2023
Q1 		$290K Buy